Securing First U.S. Source of Critical Influenza Drug Component
Securing First U.S. Source of Critical Influenza Drug Component samuel.e.seifman Wed, 20 May 2026 - 15:40 Banner Text IBMSC invested $15 million in domestic production of Shikimic Acid, which is needed to produce Tamiflu. Prior to this investment, Shikimic Acid was sourced entirely from China. With this investment, we are promoting reliable access to critica
